TARUGI, Patrizia Maria
 Distribuzione geografica
Continente #
NA - Nord America 14.361
EU - Europa 6.395
AS - Asia 5.743
SA - Sud America 789
AF - Africa 74
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 27.400
Nazione #
US - Stati Uniti d'America 14.230
GB - Regno Unito 2.410
SG - Singapore 1.924
CN - Cina 1.847
IT - Italia 1.340
HK - Hong Kong 889
SE - Svezia 728
BR - Brasile 655
DE - Germania 508
UA - Ucraina 320
RU - Federazione Russa 301
VN - Vietnam 293
FI - Finlandia 198
TR - Turchia 178
KR - Corea 164
FR - Francia 150
BG - Bulgaria 142
IN - India 102
ID - Indonesia 92
NL - Olanda 80
CA - Canada 55
JP - Giappone 51
AR - Argentina 49
BE - Belgio 49
MX - Messico 41
BD - Bangladesh 33
PK - Pakistan 30
ES - Italia 29
IE - Irlanda 28
ZA - Sudafrica 23
AT - Austria 21
PL - Polonia 20
AU - Australia 19
CO - Colombia 18
EC - Ecuador 18
IQ - Iraq 18
EU - Europa 15
IR - Iran 14
BZ - Belize 13
CH - Svizzera 13
LT - Lituania 13
EG - Egitto 11
VE - Venezuela 11
PY - Paraguay 10
KZ - Kazakistan 9
PE - Perù 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
KE - Kenya 8
MY - Malesia 8
TN - Tunisia 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
UY - Uruguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
BO - Bolivia 5
HU - Ungheria 5
JO - Giordania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
LK - Sri Lanka 4
MA - Marocco 4
TT - Trinidad e Tobago 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
KG - Kirghizistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
NE - Niger 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
GA - Gabon 1
GH - Ghana 1
Totale 27.384
Città #
Southend 1.766
Fairfield 1.667
Santa Clara 1.454
Singapore 1.266
Ashburn 1.155
Woodbridge 1.149
Houston 890
Hong Kong 876
Hefei 700
Jacksonville 699
Chandler 664
Seattle 637
Wilmington 614
Ann Arbor 522
Cambridge 488
Dearborn 403
Nyköping 396
London 347
Beijing 264
Modena 252
Los Angeles 217
Chicago 171
Seoul 158
San Diego 151
Princeton 149
Sofia 138
New York 126
The Dalles 119
Milan 118
Eugene 110
Buffalo 102
Moscow 95
Ho Chi Minh City 93
Rome 90
Helsinki 87
Council Bluffs 81
Shanghai 78
Salt Lake City 77
Izmir 74
Jakarta 72
Columbus 68
Des Moines 67
Dallas 65
Hanoi 62
Falls Church 61
São Paulo 52
Grafing 51
Elk Grove Village 44
Munich 43
Bremen 39
Naples 36
Brussels 34
Boardman 32
Frankfurt am Main 29
Redwood City 29
Nanjing 28
Rio de Janeiro 28
Tampa 28
Tokyo 28
Atlanta 26
Dublin 25
Guangzhou 23
Kunming 23
Nuremberg 22
Brooklyn 21
Detroit 21
Norwalk 21
San Jose 21
Bologna 20
Turin 20
Mexico City 19
San Mateo 19
Kent 18
Padova 18
Belo Horizonte 17
Kilburn 17
San Francisco 16
Verona 16
Montreal 15
Orem 15
Paris 15
Phoenix 15
Poplar 15
Redondo Beach 15
Reggio Emilia 15
Toronto 15
Buenos Aires 14
Florence 14
Indiana 14
Lancaster 14
Belize City 13
Fremont 13
Hounslow 13
Jinan 13
Stockholm 13
Warsaw 13
Dulles 12
Islington 12
Manchester 12
Miami 12
Totale 20.024
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.071
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 470
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 425
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 404
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol 371
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 330
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 327
Altered mRNA splicing in lipoprotein disorders 307
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 307
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 298
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 298
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 294
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations 293
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 277
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 276
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 275
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 273
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 271
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 269
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia 268
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 268
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins. 268
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 266
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum(PXE). 266
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 255
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 253
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects 248
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 247
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis 246
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 244
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 244
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B 244
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 241
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 240
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 236
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 234
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 233
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 233
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 233
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 233
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia 232
A 54-year-old diabetic man with low serum cholesterol. 229
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 227
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 227
Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. 227
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 227
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 226
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 221
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 221
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. 221
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 219
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 219
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 219
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 217
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 216
Pediatric gallstone disease in familial hypobetalipoproteinemia 215
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 215
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 211
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 210
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. 209
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 207
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. 205
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia. 203
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 202
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide 202
Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate 198
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 197
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 196
Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. 196
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 196
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 195
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 194
The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure 194
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 193
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 193
PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia 191
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function 190
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia 190
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 189
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations 189
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 187
Cholesterol synthesis in freshly isolated human leukocytes. 185
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 184
Synthesis and secretion of apolipoprotein A-I by chick skin. 184
Dyslipidemia in rats with hypothyroidism 181
Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene. 181
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 180
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome 179
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 175
Abetalipoproteinemia in an infant with severe clinical phenotype and a novel mutation 172
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 170
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 166
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 166
Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. 164
Heterozygous familial hypobetalipoproteinemia associated with fatty liver 163
Exome Sequencing in Suspected Monogenic Dyslipidemias 163
Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick. 157
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 157
Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma 155
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 155
Totale 23.788
Categoria #
all - tutte 114.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.734 0 0 0 0 0 217 285 370 105 380 206 171
2021/20222.572 151 283 219 191 56 213 151 106 282 215 454 251
2022/20232.204 257 218 159 179 252 351 40 196 294 46 131 81
2023/20241.654 73 83 149 147 301 148 131 187 74 120 49 192
2024/20255.494 184 50 118 376 1.049 849 444 333 501 241 612 737
2025/20265.054 726 466 932 1.027 1.527 376 0 0 0 0 0 0
Totale 27.585